Stockreport

MIST Stock Falls 66% Following Complete Response Letter for Cardamyst [Yahoo! Finance]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF This drug is being developed for the treatment of paroxysmal supraventricular tachycardia (PSVT), a condition characterized by sudden, rapid heartbeats. While the CRL [Read more]